# A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients

> **NCT00617604** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 218 (actual)

## Conditions studied

- De Novo Kidney Transplantation

## Interventions

- **DRUG:** Alefacept
- **DRUG:** placebo
- **DRUG:** Tacrolimus
- **DRUG:** Mycophenolate Mofetil
- **DRUG:** Steroids

## Key facts

- **NCT ID:** NCT00617604
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2016-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00617604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00617604, "A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00617604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*